Publications by authors named "Anne Vincent-Salomon"

100Publications

A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer.

Breast Cancer Res 2020 07 14;22(1):76. Epub 2020 Jul 14.

Stress and Cancer Laboratory, Equipe labelisée Ligue Nationale Contre le Cancer, Institut Curie, PSL Research University, 26, rue d'Ulm, F-75005, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-020-01311-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362513PMC
July 2020

Transcriptional and Functional Analysis of CD1c Human Dendritic Cells Identifies a CD163 Subset Priming CD8CD103 T Cells.

Immunity 2020 Aug 30;53(2):335-352.e8. Epub 2020 Jun 30.

Centre for Inflammation Biology and Cancer Immunology, The Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK; Cancer Research UK King's Health Partner Cancer Centre, King's College London, London, UK; Université de Paris, Centre for Inflammation Research, CNRS ERL8252, INSERM1149 Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.immuni.2020.06.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445430PMC
August 2020

Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer.

Cancer Discov 2020 Sep 20;10(9):1330-1351. Epub 2020 May 20.

Institut Curie, Stress and Cancer Laboratory, Equipe labélisée par la Ligue Nationale contre le Cancer, PSL Research University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-19-1384DOI Listing
September 2020

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.

NPJ Breast Cancer 2020 12;6:17. Epub 2020 May 12.

21Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41523-020-0156-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217863PMC
May 2020

EHD2 is a Predictive Biomarker of Chemotherapy Efficacy in Triple Negative Breast Carcinoma.

Sci Rep 2020 May 14;10(1):7998. Epub 2020 May 14.

Institut Curie - Centre de Recherche, PSL Research University, Membrane Dynamics and Mechanics of Intracellular Signaling team, 75248, Paris, cedex 05, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-020-65054-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224205PMC
May 2020

[Hereditary breast carcinomas pathologist's perspective].

Ann Pathol 2020 Apr 30;40(2):78-84. Epub 2020 Mar 30.

Département de médecine diagnostique et théranostique, service de pathologie, institut Curie, université Paris sciences lettres, 26, rue d'Ulm, 75005 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annpat.2020.02.023DOI Listing
April 2020

The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice.

J Pathol 2020 04 9;250(5):667-684. Epub 2020 Apr 9.

Breast Cancer Research Program, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.5406DOI Listing
April 2020

AXL Controls Directed Migration of Mesenchymal Triple-Negative Breast Cancer Cells.

Cells 2020 01 19;9(1). Epub 2020 Jan 19.

Breast Cancer Biology Group, Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cells9010247DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016818PMC
January 2020

Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences.

Nature 2019 02;566(7742):E1

Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41586-019-0883-2
Publisher Site
http://dx.doi.org/10.1038/s41586-019-0883-2DOI Listing
February 2019

Exploitation of Precision Medicine Trials Data: Examples of Long Responders From the SHIVA01 Trial.

JCO Precis Oncol 2018 19;2. Epub 2018 Oct 19.

, , , , , , , , , , , , , , , , , and , Institut Curie, Paris; , , , , , , , , , , , , , and , Institut Curie; , Institut National de la Santé et de la Recherche Médicale U900 Research Unit, Saint-Cloud; , Institut Paoli-Calmettes, Marseille; , Centre Léon Bérard, Lyon; , Centre Alexis Vautrin, Nancy; , Institut Claudius Régaud, Toulouse; , Centre René Gauducheau, Nantes; , Centre Georges-François Leclerc, Dijon; and , Versailles-Saint-Quentin-en-Yvelines University, Montigny-le-Bretonneux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/PO.18.00048DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450915PMC
October 2018

Disseminated Tumor Cells Predict Efficacy of Regional Nodal Irradiation in Early Stage Breast Cancer.

Int J Radiat Oncol Biol Phys 2019 02 4;103(2):389-396. Epub 2018 Oct 4.

Department of Medical Oncology, Institut Curie, PSL Research University, Paris and Saint Cloud, France; Circulating Tumor Biomarkers Laboratory, Siric, Institut Curie, PSL Research University, Paris, France; UVSQ, Paris Saclay University, Paris, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03603016183381
Publisher Site
http://dx.doi.org/10.1016/j.ijrobp.2018.09.033DOI Listing
February 2019

A New Transcutaneous Method for Breast Cancer Detection with Dogs.

Oncology 2019 2;96(2):110-113. Epub 2018 Oct 2.

Wound Care Unit, Anesthesia, Intensive Care and Pain Management Department, Institut Curie, Paris,

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/492895
Publisher Site
http://dx.doi.org/10.1159/000492895DOI Listing
February 2019

PML-Regulated Mitochondrial Metabolism Enhances Chemosensitivity in Human Ovarian Cancers.

Cell Metab 2019 01 20;29(1):156-173.e10. Epub 2018 Sep 20.

Institut Curie, Stress and Cancer Laboratory, Equipe Labelisée par la Ligue Nationale contre le Cancer, PSL Research University, 26, rue d'Ulm, 75005 Paris, France; Inserm, U830, 26, rue d'Ulm, Paris 75005, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15504131183056
Publisher Site
http://dx.doi.org/10.1016/j.cmet.2018.09.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331342PMC
January 2019

High rate of PIK3CA mutations but no TP53 mutations in low-grade adenosquamous carcinoma of the breast.

Histopathology 2018 Aug 7;73(2):273-283. Epub 2018 May 7.

Institut Curie, Paris Sciences Lettres Research University, Pôle de médecine diagnostique et théranostique, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13514DOI Listing
August 2018

miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers.

Nat Commun 2018 03 13;9(1):1056. Epub 2018 Mar 13.

Institut Curie, Stress and Cancer Laboratory, Equipe labelisée Ligue Nationale Contre le Cancer, PSL Research University, 26, rue d'Ulm, 75005, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-018-03348-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849633PMC
March 2018

Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer.

Cancer Cell 2018 03 15;33(3):463-479.e10. Epub 2018 Feb 15.

Institut Curie, Stress and Cancer Laboratory, Equipe labelisée Ligue Nationale Contre le Cancer, PSL Research University, 26, rue d'Ulm, 75005 Paris, France; Inserm, U830, Paris 75005, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2018.01.011DOI Listing
March 2018

Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma.

Breast Cancer Res Treat 2018 Jun 27;169(2):295-304. Epub 2018 Jan 27.

Translational Research Department, INSERM, U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut Curie, PSL Research University, 26, rue d'Ulm, 75248, Paris, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-017-4610-0
Publisher Site
http://dx.doi.org/10.1007/s10549-017-4610-0DOI Listing
June 2018

Multiple Hotspot Mutations Scanning by Single Droplet Digital PCR.

Clin Chem 2018 02 9;64(2):317-328. Epub 2017 Nov 9.

Circulating Tumor Biomarkers Laboratory, SiRIC, Translational Research Department, Institut Curie, PSL Research University, Paris, France;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2017.272518DOI Listing
February 2018

Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast.

Mod Pathol 2018 01 8;31(1):68-82. Epub 2017 Sep 8.

Pathology-Genetics-Immunology Department, Institut Curie, Paris Sciences Lettres Research University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2017.107DOI Listing
January 2018

[Internal quality control on HER2 status determination in breast cancers: Experience of a cancer center].

Bull Cancer 2017 Jul - Aug;104(7-8):608-617. Epub 2017 Jun 7.

Institut Curie, service d'anatomie et de cytologie pathologiques, 26, rue d'Ulm, 75005 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2017.05.002DOI Listing
August 2017

A phenotypic and mechanistic perspective on heterogeneity of HER2-positive breast cancers.

Mol Cell Oncol 2016 12;3(6):e1232186. Epub 2016 Sep 12.

Synergie Lyon Cancer, Plateforme de Bioinformatique 'Gilles Thomas' Centre Léon Bérard, Lyon, France; INRIA Grenoble-Rhône-Alpes, Montbonnot-Saint Martin, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/23723556.2016.1232186DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5160388PMC
September 2016

Denaturing fixatives are compatible with the NanoString nCounter platform and the Prosigna assay.

N Biotechnol 2017 May 6;36:37-41. Epub 2017 Jan 6.

Translational Research Laboratory, Institut Curie, 26 rue d'Ulm, 75248, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nbt.2017.01.001DOI Listing
May 2017

Tumoral heterogeneity of breast cancer.

Ann Biol Clin (Paris) 2016 Dec;74(6):653-660

Service d'oncologie chirurgicale, Centre René Huguenin-Institut Curie, Saint-Cloud, France, Équipe d'accueil 7285, Risques cliniques et sécurité en santé des femmes et en santé, périnatale, Université de Versailles-Saint- Quentin-en-Yvelines, Montigny-le-Bretonneux, France.

View Article

Download full-text PDF

Source
http://www.john-libbey-eurotext.fr/medline.md?doi=10.1684/ab
Publisher Site
http://dx.doi.org/10.1684/abc.2016.1192DOI Listing
December 2016

Choroidal melanoma and pregnancy.

Acta Ophthalmol 2016 Nov 24;94(7):e652-e660. Epub 2016 Mar 24.

Institut Curie, Paris Descartes University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/aos.12984DOI Listing
November 2016

[Ductal carcinoma in situ diagnosis: 3 French national guidelines].

Ann Pathol 2016 Jun 25;36(3):166-73. Epub 2016 May 25.

Département « Recommandations et bon usage du médicament », direction des recommandations, du médicament et de la qualité de l'expertise, Institut national du cancer, 52, avenue André-Morizet, 92513 Boulogne Billancourt cedex, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S02426498163002
Publisher Site
http://dx.doi.org/10.1016/j.annpat.2016.03.012DOI Listing
June 2016

Landscape of somatic mutations in 560 breast cancer whole-genome sequences.

Nature 2016 06 2;534(7605):47-54. Epub 2016 May 2.

Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature17676DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910866PMC
June 2016

Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials.

J Natl Cancer Inst 2016 Apr 23;108(4). Epub 2015 Nov 23.

Affiliations of authors:Department of Medical Oncology, Institut Curie , Paris & Saint-Cloud , France (CLT, MK, MA); EA7285 Versailles-St-Quentin-en-Yvelines University , France (CLT, RR); Investigational Cancer Therapeutics, M. D. Anderson Cancer Center , Houston, TX (AMT); Drug Development Program, Department of Medical Oncology and Hematology, Princess Margaret Hospital , Toronto , Canada (PB); Department of Genetics, Institut Curie , Paris , France (GP, CC, ER, IB); Department of Pathology, Institut Curie , Paris , France (AVS); Institut Curie / INSERM U900 , Paris , France (NS, XP); Department of Surgery, Institut Curie , Paris & Saint-Cloud , France (RR); Institut Curie, INSERM U830 , Paris , France (OD); EA7331, University of Paris-Descartes , Paris , France (IB).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv362DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830395PMC
April 2016

Circulating tumor DNA for triple-negative breast cancer diagnosis and treatment decisions.

Expert Rev Mol Diagn 2016 9;16(1):39-50. Epub 2015 Dec 9.

a Institut Curie , PSL Research University , Paris , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737159.2016.1121100DOI Listing
October 2016

ARF6-JIP3/4 regulate endosomal tubules for MT1-MMP exocytosis in cancer invasion.

J Cell Biol 2015 Oct;211(2):339-58

PSL Research University, Institut Curie, 75248 Paris, France Membrane and Cytoskeleton Dynamics, Centre National de la Recherche Scientifique, Unite Mixte de Recherche 144, 75248 Paris, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1083/jcb.201506002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621834PMC
October 2015

Unraveling the Role of Huntingtin in Breast Cancer Metastasis.

J Natl Cancer Inst 2015 Oct 20;107(10). Epub 2015 Aug 20.

Institut Curie, Paris, France (MST, JRM, CMS, LF, SL, SV, IB, AVS, SH); CNRS UMR 3306, Orsay, France (MST, JRM, CMS, SL, SH); INSERM U1005, Orsay, France (MST, JRM, CMS, SL, SH); University Paris Sud 11, Orsay, France (MST); Apoptosis, Cancer and Development Laboratory, Equipe labellisée 'La Ligue', Centre National de la Recherche Scientifique UMR5238, Université de Lyon, Lyon, France (JF, AB, PM); Department of Biostatistics and Medical Informatics, Assistance Publique-Hôpitaux de Paris (STdM); Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France (STdM); INSERM, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France (STdM); University Paris Descartes, Sorbonne Paris Cité, France (IB); Department of Pathology, Institut Curie, Paris, France (AVS); Univ. Grenoble Alpes, Grenoble Institut des Neurosciences, GIN, Grenoble, France (SH); INSERM U836, Grenoble, France (SH).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv208DOI Listing
October 2015

Secretory Breast Carcinoma: A Histopathologic and Genomic Spectrum Characterized by a Joint Specific ETV6-NTRK3 Gene Fusion.

Am J Surg Pathol 2015 Nov;39(11):1458-67

*Department of Biopathology, Institut Bergonié, Comprehensive Cancer Centre †University of Bordeaux ‡INSERM U916, Bordeaux §Pathology Department, Centre Georges François Leclerc, Dijon ¶Technopole Pathologie, Saint Etienne #CACP Les Tonnelles, Montpellier **Department of Biopathology, Institut Curie, INSERM U830, Paris, France ∥Pathology Department, CHUS Hôpital de Fleurimont, Sherbrooke, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000487DOI Listing
November 2015

Breast Cancer Cell-Derived GM-CSF Licenses Regulatory Th2 Induction by Plasmacytoid Predendritic Cells in Aggressive Disease Subtypes.

Cancer Res 2015 Jul 14;75(14):2775-87. Epub 2015 May 14.

INSERM U932, Institut Curie, Paris, France. Institut Curie, Department of Immunology, Paris, France. Center of Clinical Investigations, Curie-IGR, Paris-Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-2386DOI Listing
July 2015